ImmunoGenesis
PrivateLast Round
Grant
Dec 4, 2025
Total Funding Raised
$70.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImmunoGenesis operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in December 2025.
ImmunoGenesis is a biopharmaceutical company that develops immuno-oncology therapeutics designed to enhance immune responses in cold tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoGenesis Comparables
Compare ImmunoGenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incendia Therapeutics | 87% | |
| Isosceles Pharmaceuticals | 81% | |
| BioEclipse Therapeutics | 79% |
For institutional investors. Book with your work email.
ImmunoGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 4, 2025 | ||||
| Series A | Apr 1, 2024 | ||||
| VC Round | Jun 27, 2023 | ||||
| Grant | Aug 19, 2020 |
For institutional investors. Book with your work email.
ImmunoGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The University of Texas MD Anderson Cancer Center | VC Round |
| Cancer Focus Fund | Series A, VC Round |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 55% MoM.
- Apr 15, 2026
Poster presentation at the AACR 2026 Annual Meeting.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 9, 2026
Immunogenesis, Inc. appoints Reza Mazhari, Ph.D., and Mike Davis to its Board of Directors in Texas on Sep 9th '26.
- hiresSep 9, 2026
On Sep 9th '26, Immunogenesis, Inc. appoints Reza Mazhari to its Board of Directors in Texas, alongside Mike Davis, at a pivotal time for the company.
- hiresSep 9, 2026
Immunogenesis, Inc. appoints Mike Davis to its Board of Directors alongside Reza Mazhari in Texas on Sep 9th '26.
- hiresSep 9, 2026
Immunogenesis, Inc. appoints Mike Davis to its Board of Directors in Texas on Sep 9th '26, alongside Reza Mazhari, as the company advances its pipeline, partnering and fundraising strategy.
For institutional investors. Book with your work email.
ImmunoGenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmunoGenesis's valuation, stock price, and market status.
Is ImmunoGenesis a public or private company?
ImmunoGenesis is a private company.
What is the current stock price of ImmunoGenesis?
ImmunoGenesis is a private company, so its shares have no public market price. Caplight tracks ImmunoGenesis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmunoGenesis worth (valuation)?
Valuation information for ImmunoGenesis is not publicly available.
Can I buy ImmunoGenesis stock?
ImmunoGenesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmunoGenesis's last funding round?
ImmunoGenesis's most recent funding round was Grant on December 4, 2025.
Who are the main investors in ImmunoGenesis?
Key investors in ImmunoGenesis include Cancer Focus Fund, Cancer Prevention and Research Institute of Texas (CPRIT).
Will ImmunoGenesis IPO soon?
No public IPO plans have been announced for ImmunoGenesis.
How can I track ImmunoGenesis secondary market activity?
Caplight tracks bids, offers, and trades in ImmunoGenesis's shares on secondary markets.